ICON Medical Imaging has established a Cardiac Scientific Advisory Board comprised of world experts in several Cardiological disciplines. The Board is well positioned to advise sponsors on strategic initiatives in the areas of Cardiac Imaging, Clinical Trials and Adjudication of Clinical Events and Safety. The Board’s collective experience provides unique expertise in clinical trial design, execution, regulatory approval, and publication.
Each Board member is a renowned Academic Cardiologist with an International reputation. The board is composed of:
- Dr. Harald Becher, MD, PhD, FRCP, University of Oxford
- Dr. C. Michael Gibson, MD, MS, FACC, Harvard Medical School
- Dr. Nelson B. Schiller, MD, FACC, University of California, San Francisco
- Dr. Scott D. Solomon, MD, FACC, Harvard Medical School
The board has extensive experience in multiple areas including:
- Design of Pivotal Cardiac Trials
- Blinded Cardiac Image Interpretation
- Multimodality experience:
- Angiography
- Cardiac MRI
- CT Angiography
- Echocardiography
- Vascular ultrasound
- Venography
- Vascular Medicine - Committees for:
- Endpoint Adjudication
- DSMB
- Study Steering Committee
The group will be coordinated by Dr. Jonathan Goldman, MD, ICON Medical Imaging's Chief Medical Officer and Assistant Clinical Professor of Medicine, UCSF. Dr. Goldman has extensive experience with Echocardiography in clinical research trials, as well as the development of Phase 1, 2 and 3 protocols that have been submitted to the regulatory authorities.